Related Experiment Video
Updated: Aug 20, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
[Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)]
Waldemar Halota1, Małgorzata Pawłowska
1Katedra i Klinika Chorób Zakaznych, Akademii Medycznej im. L. Rydygiera w Bydgoszczy.
Introduction of HAART in the treatment of HIV-infection revealed, that clinical consequences of HIV-infection in these patients occur earlier than in HIV-negative ones. It may be a reason of unsuccessfully antiretroviral therapy. Another problem is hepatotoxicity of antiretroviral therapy, especially in HCV-infected patients. In the follow, treatment of chronic hepatitis C seems to be justified.
Introduction of HAART in the treatment of HIV-infection revealed, that clinical consequences of HIV-infection in these patients occur earlier than in HIV-negative ones. It may be a reason of unsuccessfully antiretroviral therapy. Another problem is hepatotoxicity of antiretroviral therapy, especially in HCV-infected patients. In the follow, treatment of chronic hepatitis C seems to be justified.
Related Concept Videos
Retrovirus Life Cycles
Hepatitis
Sexually Transmitted Infections
Viral Hepatitis I: Introduction
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis

